HEALTHCARE ELITES
Alniche Lifesciences:
Developing And Commercializing
Innovative Healthcare Products
Mr. Girish Arora
Founder & Managing Director
H ealthcare has become one of India’s largest sectors
in terms of revenue as well as employment.
Comprising of hospitals, medical devices,
consumables, clinical trials, health insurance, medical
equipment, and many more, the healthcare sector is
growing rapidly with the advancements of technology.
These technological developments in the field of healthcare
have put the experience of patients to the whole new level.
It has saved innumerable lives as patients now have access
to the best diagnostic tools, new, and superior treatments
with less pain and quicker healing. Moreover, it has
influenced medical processes as well as practices of
healthcare professionals enormously.
Today, physicians can assess patients remotely and have the
ability to precisely diagnose problems. These innovations
have improved data consumptions, communication, portal
technologies, remote monitoring, and has also augmented
the experimentations. Technology has turned out to be the
driving force behind the quality of healthcare. The
companies serving the pharma industry have reformed with
the ever-changing face of field quickly and with time the
latest and innovative commercial approaches are being
implemented with no time being wasted. A divergent
company—Alniche Lifesciences that combines the
expanded research along with the strategic focused
treatment to provide therapeutic measures.
MM 2019
Alniche: Inspired by Value, Driven by Vision
Alniche Lifesciences, a speciality healthcare company was
established in 2007, in Delhi, India and has offices in North
America and Africa. Being very strong in niche therapies,
Alniche has focus in Nephrology, Critical care,
Gastroentrology, Skinceuticals and Advanced woundcare
products. It is extremely dedicated on discovering,
developing, and commercializing innovative
pharmaceutical products that facilitates people to live life
with utmost potential. It is ready to mark its existence in
complementary market of medical devices & consumables
in the selected therapy areas that align well with their
standing pharma range and one such initiative of the firm is
entry in advanced woundcare segment. The firm provides
specialized, high quality, effective, and affordable medicine
and wellness products.
Alniche always looks for new opportunity to affiliate with
global pharma companies and also promotes profound
engagement with medical mavens. The consolidation of
strategic focus with a differentiated approach empowers the
firm to follow the new speciality divisions where therapy
gaps are significant. There are various factors focused by
the firm regarding in-licencing addressing future growth
areas, acquiring existing base to build upon including
technology, manufacturing, marketing, etc. Cost and time
advantages are also considered along with enhanced
expertise and global accessibility.
01 businessapac.com
Presently, Alniche has partnered with Global Pharma
Organizations to bring novel Global Brands in India from
various organizations including J.W. Lifesciences (Korea),
Adhezion Biomedical Inc. (USA), FzioMed (USA),
Advancis Medical (UK), PT Dermozone Pratama
(Indonesia), Biovite (Australia), and Mastix (USA). In
addition, Alniche is also working with various global
companies that focus on therapy differentiation and ground-
breaking product concepts.
Recently, Alniche has formed an R&D alliance with Delhi
Pharmaceutical Sciences & Research University (DPSRU);
India’s first Pharmacy University. This affiliation of
industry and academia promises to augment further
development of new products enabling innovations, growth
in the education system, and employment. It also ensures to
meet the medical needs of Indian population. Additionally,
Alniche has instituted awards to encourage the young
researchers for the new research and innovative products &
ideas.
Alniche is achieving these milestones because of its strong
and proficient senior management team. This expert team
comprises of cohesive and endowed professionals, making
it an exceptional combination of talent, skills, knowledge,
and business acumen.
Leader who believes in Togetherness and Growth for All
Mr. Girish Arora, the Founder and Managing Director
of Alniche Lifesciences, established the firm keeping one
thing in mind—‘Attached to the ground and aiming the
sky’. He has earned experience of more than 30 years in
Indian and global pharma market. His expertise and vision
has directed the organization into prominent therapy areas
that helped to reach an exceptional position. He has always
believed in hard work, team efforts, honesty, togetherness,
and God’s grace. His ability of decision-making and
We at Alniche Lifesciences are envisioned
to bring novel products across various therapies
and establish deep engagement with the medical
fraternity.
businessapac.com
attitude of taking business risks has also contributed to the
firm’s success. He owes a lot to his mentors who sharpened
his skills and helped him to get the feat right. He
acknowledges the efforts of Ms. Ritu Hasija, (Director
Corporate Affairs) for her incessant support right since the
inception of the company.
Challenges and Opportunities in Life Sciences Sector in
India
Over the years, India is tagged as the ‘pharmacy of the
world’ as it is the largest provider of generic drugs globally.
It supplies over 50 percent of global demand for various
vaccines, 40 percent of generic demand in the US, and 25
percent of all medicines in UK. This is not all. Companies
around the world are actively applauding the Indian CRO &
CMO for their excellent deliverables and efficiency. But
there are certain challenges faced by the pharma companies
like compliance issues and good manufacturing practices.
One more major challenge is the disjointed structure of the
industry as there are abundant generic manufacturers
leading to instability, volatility, and uncertainty. Sometimes,
the competition between big, mid-sized, and small players
can also lead to low quality compliance. To top it all, the
competitive pressure and government pricing policies adds
to the low margin profits. Even the inputs for research and
development are very low which affects the R&D
departments of the companies and the development of new
products. The stronger IP regulation has also been a big
issue for companies. But positively, the Indian government
has taken many steps to manage medicine costs and overall
affordability of healthcare expenditures.
02 MM 2019